Synergistic Effects of Selective Inhibitors Targeting the PI3K/AKT/mTOR Pathway or NUP214-ABL1 Fusion Protein in Human Acute Lymphoblastic Leukemia
| dc.contributor.author | McCubrey, James A. | |
| dc.date.accessioned | 2022-02-04T13:45:23Z | |
| dc.date.available | 2022-02-04T13:45:23Z | |
| dc.date.issued | 2016-11-03 | |
| dc.identifier.doi | 10.18632/oncotarget.13035 | |
| dc.identifier.issn | 1949-2553 | |
| dc.identifier.uri | http://hdl.handle.net/10342/9629 | |
| dc.language.iso | en_US | en_US |
| dc.subject | NUP214-ABL1 | en_US |
| dc.subject | PI3K/Akt/mTOR signaling | en_US |
| dc.subject | T-Acute Lymphoblastic Leukemia | en_US |
| dc.title | Synergistic Effects of Selective Inhibitors Targeting the PI3K/AKT/mTOR Pathway or NUP214-ABL1 Fusion Protein in Human Acute Lymphoblastic Leukemia | en_US |
| dc.type | Article | en_US |
| ecu.journal.issue | 48 | en_US |
| ecu.journal.name | Oncotarget | en_US |
| ecu.journal.pages | 79842-79853 | en_US |
| ecu.journal.volume | 7 | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- McCubreySynergisticCytotoxicEffectsofBortezomibandCK2Inhibitor.pdf
- Size:
- 4.55 MB
- Format:
- Adobe Portable Document Format
- Description:
- Article